A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease

J Infect Dis. 2006 Sep 1;194(5):666-9. doi: 10.1086/505875. Epub 2006 Jul 28.

Abstract

We investigated the effect of RANTES polymorphisms on human immunodeficiency virus type 1 (HIV-1) disease progression in an urban population of Uganda. HIV-positive individuals homozygous for the INT1.1C polymorphism, which had been associated previously with low RANTES expression, were less likely to die than were those with other genotypes (hazard ratio, 0.53 [95% confidence interval, 0.33-0.83]; P=.007). This report of a non-human leukocyte antigen genetic association with HIV-1 and/or acquired immunodeficiency syndrome disease progression in an African population reveals a genetic effect different from that reported elsewhere for African Americans and may impact therapeutic strategies targeting the RANTES pathway in HIV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chemokine CCL5 / genetics*
  • Cohort Studies
  • HIV Seronegativity
  • HIV Seropositivity / genetics*
  • HIV Seropositivity / mortality*
  • HIV Seropositivity / physiopathology
  • Homozygote
  • Humans
  • Polymorphism, Genetic*
  • Regression Analysis
  • Survival Analysis
  • Treatment Outcome
  • Uganda

Substances

  • Chemokine CCL5